Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

Free Research Reports on F, MRK, MSI and PCS Issued by the Paragon Report

Marketwired April 25, 2013

Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma

Business Wire April 24, 2013

Merck to Present Updated Interim Data from Phase II Trial Evaluating Investigational NS3/4A Protease Inhibitor MK-5172 for Chronic Hepatitis C Virus Genotype 1 Infection at the International Liver Congress(TM)

Business Wire April 23, 2013

Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C

Business Wire April 22, 2013

The Real Story Behind IBM, MRK, AMZN and AIG

Marketwired April 12, 2013

Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole)

Business Wire April 10, 2013

In the Know, Smart Investing in MDLZ and MRK

Marketwired April 10, 2013

StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie

PR Newswire April 10, 2013

Merck to Present New Data on VICTRELIS® (boceprevir) and Investigational Compounds MK-5172 and Vaniprevir for Chronic Hepatitis C Virus at The International Liver CongressTM / 2013 EASL Annual Meeting

Business Wire April 8, 2013

Strategy Behind Our Success, We Get in Early: CVX, MET, MRK and JCP

Marketwired April 8, 2013

Profitable Trading Secrets Revealed in MRK, AIG, INTC and OXY

Marketwired April 8, 2013

Don't Miss Gains in MRK, XOM, JNJ and PFE

Marketwired April 5, 2013

The Straight Truth, Investing in MRK, CVX, CAT and SLB

Marketwired April 4, 2013

Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures

PR Newswire April 4, 2013

Merck to Hold First-Quarter 2013 Sales and Earnings Conference Call on May 1

Business Wire April 1, 2013

The Reason It Trades, What's Moving MON, CVX and MRK

Marketwired April 1, 2013

S&P 500 Reaches a New All-Time High -- Index Finally Recovers From the Financial Crisis

Marketwired March 29, 2013

Before the Crowd, How We Found LVS, MRK and MA

Marketwired March 27, 2013

Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet

Business Wire March 27, 2013

Perfect Trade Setups, How to Play WFC, AMZN, PG and MRK

Marketwired March 22, 2013